Synapse - Genitourinary Oncology Service

Search Within

Genitourinary Oncology Service

Results (5696)

Loss of PTEN leads to clinical resistance to the PI3K alpha inhibitor BYL719 and provides evidence of convergent evolution under selective therapeutic pressure

Meeting Abstract

Castel, P.; Juric, D.; Won, H.; Ainscough, B.; Ellis, H.; Ebbesen, S.; Griffith, M.; Griffith, O.; Iyer, G.; Sgroi, D.; more...
Cancer Research (2014)

Fulltext@MSK | Save

Initial PET imaging and pharmacokinetic results from a Phase I/II study of Zr-89-labeled anti-STEAP1 antibody in metastatic castrate-resistant prostate cancer (mCRPC) patients

Meeting Abstract

Carrasquillo, J. A.; Danila, D. C.; Beylergil, V.; O'Donoghue, J. A.; Cheal, S. M.; Ruan, S. T.; Pandit-Taskar, N.; Fox, J. J.; Fleming, S. E.; Zanzonico, P. B.; more...
Cancer Research (2014)

Fulltext@MSK | Save

Assessment of the bone scan index in a randomized placebo-controlled trial of tasquinimod in men with metastatic castration-resistant prostate cancer (mCRPC)

Journal Article

Armstrong, A. J.; Kaboteh, R.; Carducci, M. A.; Damber, J. E.; Stadler, W. M.; Hansen, M.; Edenbrandt, L.; Forsberg, G.; Nordle, T.; Pili, R.; more...
Urologic Oncology: Seminars and Original Investigations (2014)

Fulltext@MSK | Save

Investigation of novel circulating proteins, germ line single-nucleotide polymorphisms, and molecular tumor markers as potential efficacy biomarkers of first-line sunitinib therapy for advanced renal cell carcinoma

Journal Article

Motzer, R. J.; Hutson, T. E.; Hudes, G. R.; Figlin, R. A.; Martini, J. F.; English, P. A.; Huang, X.; Valota, O.; Williams, J. A.
Cancer Chemotherapy and Pharmacology (2014)

Fulltext@MSK | Save

Greater total dose and duration of treatment with bortezomib are associated with higher incidence of chalazion and other ocular side effects

Meeting Abstract

Ganesh, K.; Batlevi, C.; Zhang, Z. G.; Hassoun, H.; Lendvai, N.; Landau, H.; Moskowitz, C. H.; Caron, P.; Motzer, R.; Giralt, S. A.; more...
Blood (2014)

Fulltext@MSK | Save

Molecular imaging with 89Zr anti-PSMA targeted PET/CT: Percutaneous biopsies of prostate cancer metastasis can be accurately performed without reinjection

Meeting Abstract

Cornelis, F.; Durack, J. C.; Pandit-Taskar, N.; Morris, M.; Solomon, S. B.
European Journal of Nuclear Medicine and Molecular Imaging (2014)

Fulltext@MSK | Save

CTLA-4 antibodies: New directions, new combinations

Journal Article

Funt, S. A.; Page, D. B.; Wolchok, J. D.; Postow, M. A.
Oncology (Norwalk) (2014)

Fulltext@MSK | Save

Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma

Journal Article

Milowsky, M. I.; Dittrich, C.; Durán, I.; Jagdev, S.; Millard, F. E.; Sweeney, C. J.; Bajorin, D.; Cerbone, L.; Quinn, D. I.; Stadler, W. M.; more...
European Journal of Cancer (2014)

Fulltext@MSK | Save

Correlation of tumour-associated macrophage, but not tumour-infiltrating lymphocyte, levels with progression-free survival in patients with metastatic renal cell carcinoma treated with axitinib

Meeting Abstract

Williams, J. A.; Martini, J. F.; Escudier, B.; Rini, B. I.; Motzer, R. J.; Tarazi, J.; Li, S.; English, P. A.
European Journal of Cancer (2014)

Fulltext@MSK | Save

Final overall survival (OS) analysis of COU-AA-302, a randomized phase 3 study of abiraterone acetate (AA) in metastatic castration-resistant prostate cancer (MCRPC) patients (pts) without prior chemotherapy

Meeting Abstract

Ryan, C. J.; Smith, M. R.; Fizazi, K.; Miller, K.; Mulders, P.; Sternberg, C. N.; Saad, F.; Griffin, T.; De Porre, P.; Park, Y. C.; more...
Annals of Oncology (2014)

Fulltext@MSK | Save